Century Therapeutics

Bristol Myers culls cell therapy deals with 2 biotechs

BMS has terminated cell therapy pacts with two biotechs amid "portfolio prioritization efforts” within the pharma, one of the affected companies said.

Gabrielle Masson Dec 16, 2024 11:19am

Acadia brings BMS vet on board as CEO—Chutes & Ladders

Sep 27, 2024 8:30am

Double autoimmune acquisitions as Century, Eliem pick up peers

Apr 11, 2024 9:06am

Gene editor Metagenomi adds C-suite execs—Chutes & Ladders

Nov 10, 2023 9:30am

Century, Elevation to cut assets, staff; Nabriva winds down

Jan 6, 2023 10:40am